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Abstract 
Smartphone-based devices are increasingly recognized to assess disease symptoms in daily life (e.g. 
ecological momentary assessment, EMA). Despite this development in digital psychiatry, clinical 
trials are mainly based on point assessments of psychopathology. This study investigated expectable 
increases in statistical power by intense assessment in randomized controlled trials (RCTs).  
A simulation study, based on three scenarios and several empirical data sets, estimated power gains of 
two- or fivefold pre-post-assessment. For each condition, data sets of various effect sizes were 
generated, and AN(C)OVAs were applied to the sample of interest (N=50-N=200).  
Power increases ranged from 6% to 92%, with higher gains in more underpowered scenarios and with 
higher number of repeated assessments. ANCOVA profited from a more precise estimation of the 
baseline covariate, resulting in additional gains in statistical power. Fivefold pre-post EMA resulted in 
highest absolute statistical power and clearly outperformed traditional questionnaire assessments. For 
example, ANCOVA of automatized PHQ-9 questionnaire data resulted in absolute power of 55 (for 
N=200 and d=0.3). Fivefold EMA, however, resulted in power of 88.9. Non-parametric and multi-
level analyses resulted in comparable outcomes. 
Besides providing psychological treatment, digital mental health can help optimizing sensitivity in 
RCT-based research. Intense assessment appears advisable whenever small sample sizes or small 
treatment effects are expected, or when applying optimization problems (e.g. machine learning). 
Simulations for various effects and a short guide for popular power software are provided for study 
planning. While feasibility of weekly assessment is established, the strategy of pre-post-EMA to boost 
statistical power needs to be further tested.   
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Statistical power in clinical research 
Statistical power is the probability to actually detect the phenomenon one is looking for (given the 
phenomenon exists). Statistical power is therefore a key component of every statistical study. As 
known from the continuing debate in neuroscience and psychological research (and the related 
replication crisis), many studies remain underpowered (Button et al., 2013; Halpern, Karlawish, & 
Berlin, 2002) - implying a high chance of overlooking effects. An assessment of effect sizes in the 
field of psychology and neuroscience revealed a median power of 0.12 to detect small effects and a 
power of 0.44 for medium effects (Szucs & Ioannidis, 2017). Considering the convention for statistical 
power (from 0.8 to 0.9), the reported lack can be classified as substantial. Finally, low statistical power 
also reduces the likelihood of statistically significant findings to actually reflect true effects. 
The situation in clinical research is comparable, where interested patients potentially volunteer in trials 
with restricted clinical value, or where studies fail in later stages of the admission process (Halpern, 
Karlawish, & Berlin, 2002; Khan, Fahl, & Brown, 2018). Even though this phenomenon does not 
present uniformly (Maddock & Rossi, 2001; Marszalek, Barber, Kohlhart, & Cooper, 2011), the 
practice of underpowered studies in the clinical field can be described as widespread and hard to 
change –ultimately increasing the risk to aggregate false findings in meta analytic evaluations (Califf 
et al., 2012; Maxwell, 2004; Roozenbeek, Lingsma, Steyerberg, & Maas, 2010; Wampold et al., 
2017), or increasing the probability of failed attempts when replicating previous studies (replication 
crisis).  
As resources in clinical research are restricted, diverse strategies to optimize statistical power have 
been developed. Those techniques can be classified into such strategies to maintain and such strategies 
to increase statistical power. Besides more elaborated procedures, a quantity of generic strategies are 
suggested in literature (Hansen, & Collins, 1994; Harrison, 2009; Roozenbeek et al., 2009). Prominent 
examples are: i) Maintaining sample size (e.g. preventing attrition and missing data), ii) maximizing 
effect size (e.g. maintaining program integrity, prognostic targeting), or iii) reducing variance (e.g. 
investigating homogenous populations). Even though a conscious consideration of these strategies 
may help to boost power, some of the described techniques entail important disadvantages. For 
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example, a highly homogenous population can restrict validity of findings, and prognostic targeting 
may result in considerable extra work.  
With the intention of finding efficient solutions, scientists also developed advanced statistical methods 
to increase power in clinical research. The most prominent strategies are: i) Imputation of missing 
data, ii) repeated measurements, iii) covariate adjustment, or iv) linear mixed models (LMM). Most of 
these techniques helped to improve clinical research. However, while some of these techniques 
increase the accuracy of a determined model (e.g. repeated measurements), others require additional 
assumptions, which potentially are prone to introducing further bias. For example, covariance 
adjustment leads to biased results, if the imputed covariate is not equally distributed over trial 
conditions (e.g. no true randomization) (Harrison, 2009; van Breukelen, 2006; Zhang et al., 2014). 
Additionally, the exact influence of a given covariate is not always clear beforehand, and, thus, 
covariate adjustment sometimes is of limited value for a priori power or sample size calculations 
(Pocock, Assmann, Enos, & Kasten, 2002; Raab, Day, & Sales, 2000).  
RCTs do not adequately capture intraindividual variation 
Randomized clinical trials (RCTs) are mainly conducted using point assessments of psychopathology 
(e.g. questionnaires applied on a random day at study onset). Recent studies suggest, however, that 
many psychological constructs (e.g. depressed mood) show substantial intraindividual variation when 
measured over time (e.g. different days). Even after improving the test length, such fluctuations 
remain undetected if point assessments are used. Fisher, Medaglia and Jeronimus (2018) showed that 
the intraindividual variance of depressive symptoms and anxiety is three times higher than 
interindividual variation. Together with other studies (Pfeiffer et al., 2015), the authors conclude that 
future research should attempt to capture intraindividual variance more extensively. Implementing 
EMA or other intense assessment strategies into RCTs can be seen as a pragmatic approach to this, as 
intraindividual fluctuations are captured over several days, while the research design stays within well-
established practices (cf. Figure 1). 
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************ Figure 1 about here **************** 
 
Intense assessments are an increasing practice in clinical research. Historically, the (practical) costs of 
multiple assessments were high, and the investigated impact of single added measurements was 
relatively small compared to other factors such as sample size or study duration (Moerbeek, 2008; 
Venter, Maxwell, & Bolig, 2002). Technological advances of the past years made intense assessments 
less effortful, leading to a clear trend towards EMA, or other forms of time series-based analyses 
(Bhugra et al., 2017; Holmes et al., 2016). Additionally, other forms of automatized intense 
assessment have proven feasible in Internet interventions (e.g. weekly or bi-weekly assessments). This 
is indicated by the umbrella-term digital mental health, covering both the provision and the evaluation 
of digital treatment. 
Considering the afore-mentioned aspects, this article investigates the impact of implementing intense 
assessment by short questionnaires or short EMA (for the purpose of this article abbreviated by 
sEMA) into RCT-based research designs. While conducting an empiric study would provide first-hand 
data, simulations yield the advantage to effortlessly test the underlying assumptions independently 
from the specific study context. In order to optimize study validity, we implemented first-hand data 
from our lab together with several external sources. The aim of this simulation study is to infer the 
extent to which intense assessment can contribute to increased power in RCTs. In this regard, the 
following scenarios (Table 1) will be simulated in order to test questionnaire-based point assessments 
of psychopathology in comparison with intense assessment: In Scenario 1 (standard scenario) we 
assumed that an average psychological short questionnaire (high correlation) is being applied once, 
twice, or five times at pre- and at post-measurement. In Scenario 2 those parameters were confirmed 
by empiric data (Klein et al., 2016; Nuij et al., 2018) on one frequently used short questionnaire - the 
automatized version of the PHQ-9 - which has been validated for digitalized application as well (Erbe, 
Eichert, Rietz, & Ebert, 2016). In Scenario 3 we assumed that sEMA (low correlation) is being used to 
assess state-like depressiveness or depressed mood (Torous & Powell, 2015) instead of applying the 
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investigated automatized questionnaire. Therefore, the correlation of the single pre- or post-
assessments in this scenario is considerably lower.  
 
************ Table 1 about here **************** 
 
METHOD 
Parameter estimation 
The parameters in Scenario 1 corresponded to average reliabilities of frequent (automatized) 
depression questionnaires in the field of clinical psychology (Drake, Csipke, & Wykes, 2013; Löwe et 
al., 2004; Vittengl, Clark, Kraft, & Jarrett, 2005). Thus, Scenario 1 will be referred to as standard 
scenario. In Scenario 2, modeling was based on two data sets. The first data set was the EVIDENT 
trial (N = 1013) (Klein et al., 2016), a multicenter trial on the effects of online depression treatment. In 
this trial, PHQ-9 was automatically applied biweekly during treatment course. The time lag between 
two of the repeated assessments varied, providing a fine-grained gradient of real world correlations. 
The data also allowed us to model a learning effect (increased correlations over time). Thus, Scenario 
2 constitutes an empirically informed analogue to Scenario 1. The estimated PHQ-9 parameters were 
confirmed by a further data set from a pilot study provided by Nuij and colleagues (2018). This second 
study investigated smartphone-based self-monitoring by applying automatized PHQ-9 items in a 
university sample, and correlations of both studies only deviated marginally (rdiff  < 0.1).  
For EMA data in Scenario 3 we set correlation to r = 0.4, as provided by data from our lab’s research 
on high frequency time series (Kaiser, & Laireiter, 2019), as well as data from Fisher and Colleagues 
(2017). Fisher and Colleagues assessed 40 individuals with generalized anxiety disorder (GAD), major 
depression (MDD), or comorbid GAD and MDD over a period of 30 days. Daily correlations of GAD 
and MDD scales (based on DSM-V criteria) ranged from r = 0.36 (SD for r = 0.19) for MDD to r = 
0.44 (SD for r = 0.20) for GAD. Additionally, average scale values fluctuated, but neither increased 
nor decreased over the course of time (adjusted R² = 0.056 - 0.007), suggesting no reactive 
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measurement due to multiple assessments. Although consistent with ongoing research from other 
EMA studies, the correlation of r = 0.4 represents an approximation, which in practice depends on 
potential disease subtypes (e.g. melancholic vs. bipolar) and the severity of a given syndrome; as well 
as the exact EMA instruction (e.g. “how do you feel at the moment” vs. “how do you feel today”) and 
the item wording. In order to account for this complexity, we present results for higher correlations in 
Appendix 1.  
Data simulation 
Simulations and graphs were produced using the R packages copula, reshape, and ggplot2. In a first 
step, the respective covariance structure was extracted from the given real-world data set. As example, 
Section 1 of Appendix 1 provides the process of data extraction for PHQ-9 questionnaire data 
(Scenario 2) based on N =1013 real world patients. The same procedure was applied for EMA data in 
Scenario 3.  
In a next step, we used Clayton und Frank copula to implement the respective covariance structure 
into the simulation model. Copulas are common mathematical functions that connect joint 
distributions and their one-dimensional marginal distributions, representing the desired covariance 
structure and providing the mathematical base for generation of data sets. To assure correctness of 
generated data sets, Bernstein estimator indicated goodness-of-fit for each Scenario 1-3 (cf. Figure 2 
of Appendix 1), and the three assessment types: single-, two-, or fivefold. Bernstein estimators are 
polynomials for estimating fit of smooth distributions (Leblanc, 2012) on a closed interval (e.g. 
statistical power between 0 % and 100 %). Again, PHQ-9 data from Scenario 2 serves as example for 
this simulation step (Appendix 1, Section 2), with the corresponding dependence structure for pre-to-
post-assessments (Section 2.1), as well as repeated pre- and repeated post-measures (Section 2.2). 
Figures 2 and 3 of Appendix 1 demonstrate the fit between empiric data (blue lines) and simulation 
model by Bernstein estimator (red curve). After fitting the model, final patient data sets can be 
generated. For our example, this resulted in smooth slightly skewed distributions (Figure 4 of 
Appendix 1). We produced 1000 virtual RCTs for 62 different effect sizes and the sample sizes of N = 
50, 100, 150, 200.  
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In a last step, the statistical model of interest (ANOVA or ANCOVA; and LMM or non-linear 
Bootstrap permutation test for additional analyses) was performed on the 62*1000 virtual RCTs of 
Scenarios 1 - 3. Whenever applicable, the generated pre- and post-values (two-, or fivefold) were 
averaged for each simulated patient. For example, if a simulated patient would score 9, 13, 14, 8, 10 
on the PHQ-9 at pre-measurement, the resulting value would be 10.8 scale points. This process led to 
the intended reduction of within-subject error variance in the applied statistical model.  
Finally, single results were logged, and statistical power was calculated as the proportion of significant 
results over all conducted tests (e.g. 800 significant results over 1000 applied AN(C)OVAs: power = 
80%). Corresponding results were printed by power curves mapping effect size (x-axis) and achieved 
power (y-axis). Additional power curves are provided in Sections 3 - 5 of Appendix 1. 
 
RESULTS 
Standard scenario 
In Scenario 1 we tested the influence of multiple assessments on achievable power in questionnaire-
based RCTs. Figure 2 depicts power curves as a function of sample size and number of assessments. 
Accordingly, ANOVA without multiple assessments resulted in lowest power (e.g. 53 % for N = 50, d 
= 0.63), while ANOVA with fivefold questionnaire assessments (e.g. 65 % for N = 50, d = 0.63) and 
ANCOVA without multiple assessments (e.g. 63 % for N = 50, d = 0.63) resulted in comparable 
power. With a clearly discernible difference, power was highest for ANCOVA with 5 pre-post-
assessments (e.g. 81 % for N = 50, d = 0.63). Furthermore, increases in sample size resulted in higher 
power (steeper curves for bigger samples), but the proportion of gained power remained constant 
(green line). This indicates, that multiple questionnaire-based assessments yield advantages 
independently of the respective sample size. Twofold pre-post-assessments, however, resulted in only 
marginal power increases. 
 
************ Figure 2 about here **************** 
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Empiric short questionnaire scenario  
In Scenario 2, we tested the influence of multiple assessments on gained power based on a model 
implementing empiric parameters (automatized PHQ-9 assessments) from two external sources. 
Results (Figure 3) coincided with Scenario 1, and, thus, support the validity of standard scenario (e.g. 
simple ANOVA 49 %; fivefold pre-post-assessments ANCOVA 82 %).  
 
************ Figure 3 about here **************** 
 
Empiric EMA scenario 
In Scenario 3, we tested the influence of short EMA assessments on power in RCTs. Due to their 
weaker auto-correlation, potential power gains are (per sé) expected to be higher in this scenario. The 
results are depicted in Figure 4, where fivefold sEMA of ANOVA (e.g. 78 % for N = 50, d = 0.63) 
already outperformed standard ANCOVA. Power was highest in fivefold sEMA combined with 
baseline ANCOVA (e.g. 94 % for N = 50, d = 0.63), and lowest if only twofold sEMA was applied.  
 
************ Figure 4 about here **************** 
 
Comparison of absolute power  
Additionally, the absolute power of both strategies can be compared. Table 2 presents proportions of 
relative and absolute power gains for Scenario 2 (empiric PHQ-9 data) and Scenario 3 (empiric 
sEMA). Relative increases in power ranged from 6% to 92%, with highest increase rates for more 
severely underpowered studies. Importantly, sEMA outperformed point assessments of 
psychopathology in terms of absolute statistical power. For example, ANCOVA of simple PHQ-9 
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questionnaire data resulted in an absolute statistical power of 55 (for N = 200 and d = 0.3). Fivefold 
sEMA with baseline as covariate, however, resulted in power of 88.9 to detect a comparable effect in a 
comparable sample.  
 
************ Table 2 about here **************** 
 
 
Additional findings 
In order to test the robustness of findings, we conducted additional simulations based on non-
parametric tests and simple linear mixed models (LMM). As a proof of concept, and to avoid 
redundancy, the corresponding findings are presented in Appendix 1. Non-parametric and parametric 
tests yielded comparable results, indicating good robustness independent of scaling (ordinal vs. 
interval data). LMM led to comparable effects as obtained in ANCOVA, if baseline was used as 
covariate. A plot of apriori (predefined) versus observed effect sizes is provided in Appendix 1, 
Section 6. This plot indicates that averaging across twofold or fivefold pre- or post-assessments (to 
achieve the intended variance reduction) did not bias the results (e.g. overestimation of true effect).  
 
DISCUSSION 
This study examined the effects of intense pre-post-assessment on achievable statistical power in 
RCTs. It is based on the assumption that repeated assessments will allow more precise estimation of 
psychopathology, reducing unrespectable variance within subjects (in terms of time-related 
fluctuations). Reduced error variance increases the proportion of explainable to unexplainable 
variance, resulting in increased statistical power, and, thus, higher sensitivity to changes. To test the 
magnitude of expectable power increases, three scenarios were simulated.  
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Principal findings indicate that RCTs with intense assessment lead to power gains beyond standard 
methods of point assessment of psychopathology. A simulation based on empiric parameters from two 
external sources (Scenario 2) coincided with the corresponding standard scenario (Scenario 1; 
assessment by short questionnaire), indicating high generalizability of presented findings. 
Furthermore, short pre-post EMA (sEMA) resulted in highest absolute statistical power when 
compared to automatized point assessments. Thus, findings suggest that sEMA or comparable forms 
of intensive repeated assessment may be well suited for implementation into RCT-based research, as 
they can outperform standard methods. In the wider perspective, multiple assessments could provide a 
strategy to tackle the problem of underpowered studies in clinical research (Khan, Fahl, & Brown, 
2018; Roozenbeek, Lingsma, Steyerberg, & Maas, 2010; Szucs & Ioannidis, 2017), as small sample 
size situations exhibited highest improvements.  
Questionnaire-like data (high correlation) 
The principal study results indicated a clear superiority of fivefold over twofold pre-post-assessments, 
with the latter leading to marginal power increases (cf. Figure 2). This finding is in line with studies 
indicating only small power gains through occasional repeated assessments (Moerbeek, 2008; Venter, 
Maxwell, & Bolig, 2002).  
For fivefold pre-post-assessments, power gains of ANOVA were comparable to applying point 
assessments and ANCOVA with baseline as covariate (cf. Figure 2). So far, baseline ANCOVA 
without intense assessments would be indicated as it constitutes the most efficient way to optimize 
power (van Breukelen, 2006; Zhang et al., 2014). However, as multiple pre-assessment provides a 
more precise estimation of the investigated construct (e.g. depressed mood), the precision of the 
baseline covariate also improved. According to our simulation, the combination of intense assessment 
and ANCOVA led to substantial power gains. Contrary to the sometimes unknown influence of 
additional third variables in ANCOVA (Harrison, 2009; Pocock, Assmann, Enos, & Kasten, 2002), 
potential sample size reductions can be approximated by standard parameters (e.g. retest reliability). 
This means that multiple assessment is applicable for a priori sample size calculation, and could 
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thereby help to reduce the costs of conducting clinical research. Appendix 2 provides a pragmatic 
guide on how expectable sample reductions can be approximated by the popular G*Power software.  
EMA-like data (low correlation)  
Even though EMA and other time series-based procedures are increasingly used in clinical research 
(Bhugra et al., 2017; Holmes et al., 2016), the practice of implementing them into RCTs to improve 
statistical power is not widespread. However, first empirical evidence exists. For example, a recent 
study on the comparison of EMA-based and paper-pencil measures of depression and anxiety reported 
a 25-50% improvement of change sensitivity (number needed to treat, NNT) with 10 pre- and 10 post-
assessments (Moore, Depp, Wetherell, & Lenze, 2016). In this context, previous simulations revealed 
that more weakly related constructs can result in higher statistical power in multiple assessment 
situations (Basagana, & Spielman, 2011, p. 61). Further supportive evidence comes from a medical 
study on irritable bowel syndrome (IBS), in which sensitivity of retrospective symptom rating was 
improved by EMA (Vork et al., 2019). In this study, 10 assessments were taken during seven 
consecutive days per measurement period. Taken together, recent empiric findings support the 
assumption that change in psychological constructs could rather be evaluated by time series then by 
point assessments of psychopathology (Fisher, Medaglia, & Jeronimus, 2018; Moore, Depp, 
Wetherell, & Lenze, 2016, Vork et al., 2019). Such intense assessments could simultaneously serve to 
investigate temporal dynamics of disease symptoms (or syndromes) (Bos, Schoevers, & Rot, 2015), to 
improve classification (Pfeiffer et al., 2015), and to improve statistical power in clinical trials.  
Regarding the optimal number of assessments per measurement period (e.g. baseline, post-assessment, 
and follow-up) a range of 5 to 10 assessments appears advisable, to balance expectable gains in 
statistical power against burden of assessment. While the above mentioned empiric studies (Moore et 
al., 2016; Vork et al., 2019) implemented 10 assessments, our computer simulation suggests 
reasonable improvements with 5 valid assessments. Therefore, 6 to 7 assessments per measurement 
period appear advisable, if 20 – 30 % missing data are being taken into account. In this context, 
common statistical power calculators can be helpful for providing a rough estimation of expectable 
power increases. We therefore provide a pragmatic guide on how sample reductions can be 
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approximated by the popular G*Power software in Appendix 2. At this, restrictions exists as many 
open software calculators only allow to specify one single value in the covariance matrix, assuming 
equal correlations between groups or within repeated measurements. Furthermore, models usually 
entail equidistance between assessments (e.g. continuous weekly or bi-weekly point assessments over 
the treatment period), leading to differences in statistical model and empiric data (including additional 
variance caused by treatment). In contrast, correlations of repeated assessments between and within 
each measurement period of sEMA will deviate considerably. Appendix 2 therefore features a table to 
estimate deviation between G*Power and our model. Independently from the specific assessment 
strategy (questionnaire- or EMA-based) the overall convergence of both models was sufficient to 
allow sample size planning.  
 
Pros & cons of sEMA 
Summing up, sEMA (and multiple applications of short questionnaires) might constitute a promising 
approach to tackle some current problems in clinical research by blending EMA and RCT-based 
paradigms. While daily EMA assessments over the entire study period may quickly overload patients, 
a limited number of assessments in the pre- and post-phase of a clinical study seems much more 
feasible (Verhagen et al., 2016). Nevertheless, this additional effort results in significant increase in 
data quality. Especially small trials in early research stages and lager trials with active comparators 
(e.g. testing against the gold-standard treatment) could benefit from selecting a set of items to be 
assessed intensely. In this regard, feasibility of sEMA might be higher for the suggested research 
context (e.g. multiple baseline designs), and lower for standard application in routine care. On the 
other hand, many routine Internet-based treatments feature intense assessment in terms of weekly 
monitoring, and comparable approaches are being implemented into routine blended treatment (Lutz, 
Rubel, Schwartz, Schilling, & Deisenhofer, 2019). Thus, weekly assessments can be a useful 
alternative to optimize statistical power. Finally, the decision between those two forms of intense 
assessment depends on study purpose (e.g. focus on treatment process versus outcome, or type of 
mediation analysis, or assessment intensity of process variables).      
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As a related topic, EMA has been suspected to not only measure, but also influence symptoms of 
mental health. Until now, the exact circumstances of “reactive measurement” in psychiatric research 
are unknown (Mehl & Conner, 2011; Schrimsher, & Filtz, 2011), and corresponding studies are still 
ongoing (van Ballegooijen et al., 2016). Experts previously suggested that EMA may be 
contraindicated for patients with severe psychiatric conditions (Rot, Hogenelst, & Schoevers, 2012), or 
with high social desirability (e.g. alcohol intake) (Johnson et al., 2009). Amongst other strategies to 
counteract potential reactivity (and to increase engagement) (Sandstrom, Lathia, Mascolo, & 
Rentfrow, 2016), Torous and colleagues (2015) investigated the benefits of item-shuffling. Regarding 
the empiric data of the current study, we did not find any reactive measurement in terms of increased 
or decreased scale values over the course in time. However, in order to test the potential impact of 
another form of reactivity (increased auto-correlations), such a learning effect was implemented into 
Scenario 2. This effect did not excerpt any relevant influence on the presented results. To consider 
pros- and cons of intense assessment an overview of relevant aspects is provided in Table 3.  
************ Table 3 about here **************** 
 
Recommendations for applied researchers: 
 Use intense assessment regimes in RCTs in order to optimize statistical power. 
 Apply the same regime in the experimental and control group to assure study validity. 
 Choose at best 10 valid repeated assessments for the active treatment period (pre-to-post). 
 Account for missing data.  
 Consider EMA as a useful alternative to classic point assessments of psychopathology.  
 Consider sEMA whenever psychopathology needs to be assessed with maximum precision 
before and after treatment (e.g. to estimate treatment effects).  
 Consider sEMA for process studies, for example relating psychological constructs to 
physiological point assessments (e.g. EEG or fMRI), or treatment moderators and mediators, 
or optimization problems (e.g. machine learing). 
 Use information featured in figures and Appendix 1 & 2 for sample size planning.  
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 Be aware of restrictions (e.g. limited number of constructs to be assessed) and possible risks of 
intense assessment (e.g. higher burden for patients). 
 
Strengths and limitations  
This study has several noteworthy strengths and limitations. Amongst its most important strengths, 
reported findings are based on numerous data sets and simulations and therefore reproducible and well 
interpretable, providing insights which are merely independent from fluctuations in single trials. 
Additionally, a replication modeled after standard parameters (Scenario 1) and complementing 
analyses based on non-parametric tests and basic linear mixed models supported principal findings. 
Furthermore, the simulation process was carried out by four authors (RS, MS, TK, WT), resulting in a 
high degree of mutual control in a multidisciplinary team. During the process, two models were 
developed independently, and integrated stepwise. 
Regarding the study limitations, further evidence from empiric research is warranted for some forms 
of intense assessment. Due to the novelty of sEMA, only scarce empiric evidence for its positive 
impact on statistical power exists (Moore et al., 2016; Vork et al., 2019). Additionally, findings may 
not account for psychiatric conditions with more complex symptom dynamics (e.g. PTSD or eating 
disorders), or whenever strong patient reactivity is being expected. As a further limitation, the 
presented simulations did not include missing data or dropout. Therefore, the calculated effects will be 
lower at an increasing dropout rate. On the other hand, intense assessments damper the impact of 
missing out single assessments – which is equivalent to dropout in RCTs. At this, the investigated 
maximum of five assessments per measurement occasion was set somewhat arbitrary, with eight or ten 
assessments constituting a feasible alternative. The specific impact of missing data will depend on 
study context. While data missing at random (e.g. 20 % missing data) has relatively small impact on 
reported findings and easily can be compensated by one extra assessment (e.g. 6 instead of 5), 
scenarios with very low participant engagement at post treatment (e.g. with high proportions of 
dropout) will lead to reduction in beneficial effects on statistical power. As a last limitation, more 
complex methods of time series analysis would have been applicable as well. One such strategy 
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includes complexity or entropy measures from non-linear time series, as investigated by our 
workgroup (Kaiser & Laireiter, 2018). Alternatively, hierarchical methods (LMM) are one suggested 
standard method in classic and recent literature (Schwartz, & Stone, 1998; Bolger & Laurenceau, 
2013). To speed up the simulation process, our principal analysis was based on AN(C)OVA, with 
complementary analyses based on LMM and permutation tests. At this, the conducted bias analysis 
indicated robustness of findings (cf. Appendix 1). One possible explanation is that the method of 
averaging over multiple assessments constitutes a data aggregation and not a disaggregation procedure 
(Nezlek, 2001), which optimize other statistical requirements, such as the underlying normal 
distribution or homogeneity of variances, of the simulation process.  
Conclusion 
To sum up, intense assessment strategies indicate clear superiority of multiple assessments over 
frequently used point assessments of psychopathology. At this, time series-based procedures (such as 
EMA) can outperform classic point assessments by a comparably low number of repeated 
assessments. This is because psychological constructs underlie natural fluctuations which cannot be 
addressed by means of test extension. As automatization has made multiple assessments less effortful, 
intense assessment strategies are seen more frequently in clinical and in research context (e.g. weekly 
assessment, or multiple baseline assessment). Further ongoing evidence on sEMA’s feasibility is 
promising, but more research in diverse populations is needed. As clinical research suffers from 
underpowered studies, intense assessment strategies should find more recognition in RCT-based 
designs.  
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Figure 1. Different slopes of improvement as a function of measurement day during pre- and post-
assessment. 
Figure 2. Power for standard scenario. 
Figure 3. Power for EMA data. 
Figure 4. Power modeled according to empiric data. 
 
 
Table 1. Scenarios to test the impact of sEMA 
Table 2. Achieved power through intense pre-post-assessment (sEMA) 
Table 3. Advantages and disadvantages of sEMA 
 
 
Figure 1. Different slopes of improvement as a function of measurement day introduce measurement 
error. 
 
 
 
 
 
 
 
 
 
Note. Point assessments of psychopathology (by standard questionnaires) introduce measurement error 
as symptoms fluctuate over time. For example, for a questionnaire with 16 items and a standard 
deviation of SD = 5, a fluctuation of 1 point on 2 items of a given Likert scale would result in 40% 
fluctuation of SD. This imprecision increases if both, pre- and post-assessment, are affected equally. 
Green lines represent three slopes of single point assessments. Red lines represent averaged slopes 
over a moving window of three measurement occasions.  
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Figure 2. Power curves mapping effect size (x-axis) and achieved power (y-axis) for Scenario 1 
(standard scenario). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Green line = power gain; red line = 80% power level; dashed line: standard AN(C)OVA; solid 
line: intense assessment. 
  
With intense assessment (2-fold) 
Without intense assessment  
With intense assessment (5-fold) 
Without intense assessment 
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Figure 3. Power curves mapping effect size (x-axis) and achieved power (y-axis) for Scenario 2 
(empiric data based on automatized PHQ-9 assessments). 
 
Note. Green line = power gain; red line = 80% power level; dashed line: standard AN(C)OVA; solid 
line: intense assessment. 
With intense assessment (2-fold) 
Without intense assessment  
With intense assessment (5-fold) 
Without intense assessment 
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Figure 4. Power curves mapping effect size (x-axis) and achieved power (y-axis) for Scenario 3 
(empiric EMA data). 
 
Note. Green line = power gain; red line = 80% power level; dashed line: standard AN(C)OVA; solid 
line: intense assessment. 
  
With short EMA (2-fold) 
Without short EMA  
With short EMA (5-fold) 
Without short EMA  
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Table 1. Scenarios to test the impact of intense assessment 
 Scenario 1 
(standard 
scenario) 
Scenario 2  
(emp. trial 
data) 
Scenario 3 
(emp. EMA 
data) 
Assessment method Average 
questionnaire 
Automatized 
PHQ-9 
Automatized 
EMA 
Reliability of repeated pre-assessments (r)  0.7 ≈ 0.4 - 0.65   0.4 
Reliability of repeated post-assessments (r)  0.7 ≈ 0.4 - 0.65  0.4 
Quantity of pre-assessments 2 or 5  2 or 5 2 or 5  
Quantity of post-assessments 2 or 5  2 or 5 2 or 5  
Abbreviations: EMA = ecological momentary assessment; PHQ-9 = Patient Health Questionnaire (depression); r 
= auto-correlation. 
 
Table 2. Achieved power through intense pre-post-assessment by automatized short questionnaires or 
sEMA 
  
ANOVA 
 
ANCOVA 
 Standard 
pre-post 
Twofold 
pre-post 
Fivefold pre-
post 
Standard pre-
post 
Twofold pre-
post 
Fivefold pre-
post 
Simulation Power (%) Power (%*) Power (%*) Power (%) Power (%*) Power (%*) 
Scenario 2 
(automatized PHQ-
9) 
      
N = 50; d = 0.8a 68.0 (100) 72.1 (106) 76.7 (113) 79.8 (100) 83.8 (105) 90.4 (113) 
N = 100; d = 0.5a 58.3 (100) 61.7 (106) 66.7 (114) 70.1 (100) 76,7 (109) 83.8 (120) 
N = 200; d = 0.3a 43.8 (100) 47.9 (109) 52.9 (121) 55.0 (100) 60.4 (110) 71,3 (130) 
Scenario 3 
(automatized EMA) 
      
N = 50; d = 0.8a 58.2 (100) 71.9 (123) 92.8 (159) 75.2 (100) 89.5 (119) 99.4 (132) 
N = 100; d = 0.5a 51.3 (100) 64.4 (125) 87.2 (169) 66.9 (100) 82.3 (123) 97.5 (146) 
N = 200; d = 0.3a 38.4 (100) 50.0 (130) 73.9  (192) 51.4 (100) 67.5 (131) 88.9 (173) 
Note. Fivefold sEMA (columns 3 and 6 of Scenario 3) clearly outperforms questionnaire-based point 
assessments of psychopathology (columns 1 and 4 of Scenario 2) in terms of absolute statistical power.  
Abbreviations: sEMA = intense pre-post-Ecological Momentary Assessment; %* = increase in percent relative 
to reference; N = number of participants. a Cohen’s d. 
 
Table 3. Advantages and disadvantages of intense assessment 
Advantage Disadvantage 
Fits recent trends in clinical research  More feasibility research needed 
Increases measurement precision  May act as intervention 
Reduces impact of missing assessments Increases burden for participants  
Provides additional information on disease dynamics Applicability decreases with number of items 
Improves triangulation of data sources (e.g. neuroscience)  
Increases statistical power / reduces required sample size  
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